Chicago Jury Verdict: Abbott Laboratories Ordered to Pay 70 Million Dollars
A Chicago jury has ordered Abbott Laboratories (ABT.N) to pay 70 million dollars in damages. The verdict concerns a high-profile case in which the company was accused of concealing information about the risks of formula intended for premature infants.
Case Overview: Fatal Disease and “Duty to Warn”
The plaintiffs were represented by four families (whose claims were consolidated into a single proceeding). According to their allegations, Abbott failed to provide adequate warning that its cow’s milk-based products could cause necrotizing enterocolitis (NEC) — a potentially fatal intestinal disease that is particularly dangerous for premature newborns.
• Verdict Amount: 70 million US dollars.
• Basis of Claim: Inadequate disclosure by the manufacturer regarding the risks associated with the product to consumers/medical personnel.
• Context: This is one of the first verdicts among hundreds of similar claims filed against the company across the United States.
Analysis by Kh & Partners Lawyers
This case is significant from the perspective of tort law (Tort Law), particularly in the area of product liability.
According to our experts, the following legal aspects have been identified:
- Violation of the “Duty to Warn”: Legally, a manufacturer is obliged to provide the consumer not only with information about the usefulness of a product, but also about all scientifically substantiated risks that may accompany its use. In Abbott’s case, the jury concluded that the company prioritized marketing over safety transparency.
- Scale of Damages and Preventive Function: The 70 million dollars is not merely compensation; in such high-profile cases, the verdict often carries a so-called “punitive” character, aiming to warn other large corporations to devote greater attention to product safety testing.
- Consolidation of Claims: The consolidation of the claims of four families proved strategically advantageous for the plaintiffs, as it demonstrated a systemic issue rather than an isolated incident to the court. This practice is frequently applied in cases of mass torts.
Kh & Partners Conclusion: “This verdict is a clear signal to the giants of the pharmaceutical and food industries. A product defect is not limited to a design flaw; the absence or insufficiency of a warning is legally equivalent to a product defect. We expect this decision to have a domino effect on hundreds of other pending cases against Abbott.”
Why Do Clients Trust Us?
▪️ 33+ years of experience in the field of law
▪️ 160+ lawyers in a global network
▪️ 2000+ business clients and satisfied customers
▪️ 96% successful cases and 100+ acquittals
▪️ ISO standard and the highest quality of service
▪️ insured legal services
🌍 International scale — our geography includes countries: Georgia, USA, France, Spain, Ukraine, Turkey, China, South Korea and others.
Our philosophy: peace, reliability and victory!
📞 +995 595 17 17 41
✉️ info@khlaws.com
📍 Tbilisi, Georgia
ანალიტიკა
